Literature DB >> 11208180

Lysophosphatidic acid enhances healing of acute cutaneous wounds in the mouse.

J S Demoyer1, T C Skalak, M E Durieux.   

Abstract

Lysophosphatidic acid is a phospholipid growth factor and intercellular signaling molecule released by activated platelets and injured fibroblasts that affects keratinocytes, fibroblasts, neutrophils,and monocytes. We therefore hypothesized that lysophosphatidic acid could influence the inflammation and reepithelialization phases of wound healing. Lysophosphatidic acid (100 microM) was applied daily for 5 days to 2 mm-diameter excisional mouse ear skin wounds and re-epithelialization was measured. We also evaluated whether the bioactivity of lysophosphatidic acid could be increased by zinc (Zn2+, 1 mM). Inflammatory cells were counted in wound sections after 1, 3, or 5 days of healing. Reepithelialization was accelerated significantly by either lysophosphatidic acid or lysophosphatidic acid + Zn2+ (p < 0.01 and p < 0.0001, respectively). Both lysophosphatidic acid solutions significantly increased the amount of new epithelium in the wounds on days 1, 2, and 3 (p < 0.05). Little wound area remained on day 4, and all wounds were fully reepithelialized by day 5. Lysophosphatidic acid did not affect the number of neutrophils or macrophages present in the wound area. Our findings show that lysophosphatidic acid increased the amount of reepithelialization in the early stages of cutaneous wound healing in excisional ear wounds, without affecting inflammatory function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11208180     DOI: 10.1046/j.1524-475x.2000.00530.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  15 in total

Review 1.  ["Alternative" effects of local anesthetic agents].

Authors:  S Pecher; B W Böttiger; B Graf; M W Hollmann
Journal:  Anaesthesist       Date:  2004-04       Impact factor: 1.041

2.  Production of lysophosphatidic acid in blister fluid: involvement of a lysophospholipase D activity.

Authors:  Juliette Mazereeuw-Hautier; Sandra Gres; Madie Fanguin; Clotilde Cariven; Josette Fauvel; Bertrand Perret; Hugues Chap; Jean-Pierre Salles; Jean-Sébastien Saulnier-Blache
Journal:  J Invest Dermatol       Date:  2005-09       Impact factor: 8.551

Review 3.  In situ tissue regeneration: chemoattractants for endogenous stem cell recruitment.

Authors:  Wendy S Vanden Berg-Foels
Journal:  Tissue Eng Part B Rev       Date:  2013-07-11       Impact factor: 6.389

Review 4.  Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis.

Authors:  Barry S Shea; Andrew M Tager
Journal:  Proc Am Thorac Soc       Date:  2012-07

5.  Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma.

Authors:  Flavia V Castelino; Jon Seiders; Gretchen Bain; Sarah F Brooks; Christopher D King; James S Swaney; Daniel S Lorrain; Jerold Chun; Andrew D Luster; Andrew M Tager
Journal:  Arthritis Rheum       Date:  2011-05

6.  Systems-Level Lipid Analysis Methodologies for Qualitative and Quantitative Investigation of Lipid Signaling Events During Wound Healing.

Authors:  Dayanjan S Wijesinghe; Charles E Chalfant
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-11       Impact factor: 4.730

7.  Cross-talk between lysophosphatidic acid receptor 1 and tropomyosin receptor kinase A promotes lung epithelial cell migration.

Authors:  Ling Nan; Jianxin Wei; Anastasia M Jacko; Miranda K Culley; Jing Zhao; Viswanathan Natarajan; Haichun Ma; Yutong Zhao
Journal:  Biochim Biophys Acta       Date:  2015-11-17

8.  Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2).

Authors:  James J A Contos; Isao Ishii; Nobuyuki Fukushima; Marcy A Kingsbury; Xiaoqin Ye; Shuji Kawamura; Joan Heller Brown; Jerold Chun
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

9.  Lysophosphatidic acid promotes cell migration through STIM1- and Orai1-mediated Ca2+(i) mobilization and NFAT2 activation.

Authors:  Ralph Jans; Laura Mottram; Darren L Johnson; Anna M Brown; Stephen Sikkink; Kehinde Ross; Nick J Reynolds
Journal:  J Invest Dermatol       Date:  2012-10-25       Impact factor: 8.551

10.  Prediction of sepsis mortality using metabolite biomarkers in the blood: a meta-analysis of death-related pathways and prospective validation.

Authors:  Jing Wang; Yizhu Sun; Shengnan Teng; Kefeng Li
Journal:  BMC Med       Date:  2020-04-15       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.